HealthLynked (HLYK) Common Equity (2016 - 2026)

HealthLynked has disclosed Common Equity across 11 years of filings, most recently posting -$7.0 million for Q1 2026.

• In Q1 2026, Common Equity fell 69.72% year-over-year to -$7.0 million; the TTM figure through Mar 2026 stood at -$7.0 million (down 69.72% YoY), while the FY2025 annual figure was -$5.8 million, down 84.13% from the prior year.
• Common Equity retreated to -$7.0 million in Q1 2026, from -$5.8 million in the prior quarter.
• Over the last five years, Common Equity for HLYK reached as high as $6.1 million in Q1 2022 and fell as low as -$7.0 million in Q1 2026.
• The 5-year median for Common Equity is $221494.0 (2024), against an average of -$645099.6.
• Annual changes were most pronounced in 2023 — Common Equity jumped 155.92% — and 2025, when it plunged 1967.95%.
• A 5-year view of Common Equity shows it stood at $314450.0 in 2022, then jumped by 155.92% to $804730.0 in 2023, then plunged by 488.85% to -$3.1 million in 2024, then tumbled by 84.13% to -$5.8 million in 2025, then slipped by 21.87% to -$7.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered -$7.0 million, -$5.8 million, and -$5.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.